These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24933041)

  • 1. The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases.
    Casini G; Dal Monte M; Fornaciari I; Filippi L; Bagnoli P
    Prog Retin Eye Res; 2014 Sep; 42():103-29. PubMed ID: 24933041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
    Filippi L; Dal Monte M; Casini G; Daniotti M; Sereni F; Bagnoli P
    Med Res Rev; 2015 May; 35(3):619-52. PubMed ID: 25523517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.
    Martini D; Monte MD; Ristori C; Cupisti E; Mei S; Fiorini P; Filippi L; Bagnoli P
    J Neurochem; 2011 Dec; 119(6):1317-29. PubMed ID: 21988318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice.
    Dal Monte M; Casini G; la Marca G; Isacchi B; Filippi L; Bagnoli P
    Exp Eye Res; 2013 Jun; 111():27-35. PubMed ID: 23528535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of β1/2 adrenergic receptor deletion in a model of oxygen-induced retinopathy.
    Dal Monte M; Cammalleri M; Mattei E; Filippi L; Bagnoli P
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):59-73. PubMed ID: 25503457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Zheng Z; Chen H; Xu X; Li C; Gu Q
    Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The β3 adrenoceptor in proliferative retinopathies: "Cinderella" steps out of its family shadow.
    Cammalleri M; Amato R; Dal Monte M; Filippi L; Bagnoli P
    Pharmacol Res; 2023 Apr; 190():106713. PubMed ID: 36863427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
    Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
    Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy.
    Tokunaga CC; Mitton KP; Dailey W; Massoll C; Roumayah K; Guzman E; Tarabishy N; Cheng M; Drenser KA
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1884-92. PubMed ID: 24550366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.
    Filippi L; Cavallaro G; Bagnoli P; Dal Monte M; Fiorini P; Donzelli G; Tinelli F; Araimo G; Cristofori G; la Marca G; Della Bona ML; La Torre A; Fortunato P; Furlanetto S; Osnaghi S; Mosca F
    J Pediatr; 2013 Dec; 163(6):1570-1577.e6. PubMed ID: 24054431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.
    Filippi L; Cavallaro G; Fiorini P; Daniotti M; Benedetti V; Cristofori G; Araimo G; Ramenghi L; La Torre A; Fortunato P; Pollazzi L; la Marca G; Malvagia S; Bagnoli P; Ristori C; Dal Monte M; Bilia AR; Isacchi B; Furlanetto S; Tinelli F; Cioni G; Donzelli G; Osnaghi S; Mosca F
    BMC Pediatr; 2010 Nov; 10():83. PubMed ID: 21087499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy.
    DeNiro M; Al-Halafi A; Al-Mohanna FH; Alsmadi O; Al-Mohanna FA
    Mol Pharmacol; 2010 Mar; 77(3):348-67. PubMed ID: 20008515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
    Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
    J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intraocular antiangiogenic drugs in clinical application advantages and disadvantages].
    Li XX
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):870-3. PubMed ID: 23302238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel drug delivery systems for retinal diseases. A review.
    Lee SS; Robinson MR
    Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
    Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
    J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.
    Dal Monte M; Casini G; Filippi L; Nicchia GP; Svelto M; Bagnoli P
    J Mol Med (Berl); 2013 Dec; 91(12):1407-19. PubMed ID: 23907236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
    Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.